These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3541758)

  • 1. [Value of cutaneous immunofluorescence in the etiological diagnosis of a disease with antinuclear antibodies].
    Lévêque E; Dréno B; Planchon B; Bureau B; Litoux P; Barrière H
    Ann Dermatol Venereol; 1986; 113(8):655-64. PubMed ID: 3541758
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of indirect immunofluorescence test by Weller and Coons for demonstration of antinuclear factors].
    Nebe H
    Dermatol Monatsschr; 1970 Oct; 156(10):913-8. PubMed ID: 4927926
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical manifestations and laboratory data of subacute cutaneous lupus erythematosus.
    Molad Y; Weinberger A; David M; Garty B; Wysenbeek AJ; Pinkhas J
    Isr J Med Sci; 1987 Apr; 23(4):278-80. PubMed ID: 3305416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fixation in vivo of antinuclear antibodies].
    Guillet G; Fizet D; Claudy A; Thivolet J
    Nouv Presse Med; 1979 Mar; 8(11):869. PubMed ID: 377217
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical usefulness of determining the antibodies to soluble nuclear antigens in various collagen diseases].
    Dziankowska-Bartkowiak B; Lutowiecka-Wranicz A; Sysa-Jedrzejowska A; Torzecka D; Waszczykowska E
    Przegl Dermatol; 1990; 77(5):332-5. PubMed ID: 2125351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinuclear antibodies in dermatology.
    Heffernan MP; Do JH; Mehta J
    Semin Cutan Med Surg; 2001 Mar; 20(1):2-13. PubMed ID: 11308133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of antibody to C5b-9 in the subclassification of lupus erythematosus.
    Magro CM; Crowson AN; Harrist TJ
    Br J Dermatol; 1996 May; 134(5):855-62. PubMed ID: 8736325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinuclear antibodies and patterns of nuclear immunofluorescence in systemic lupus erythmatosus and other collagen vascular diseases.
    Bhuyan UN; Malaviya AN
    Indian J Med Res; 1976 Jun; 64(6):895-902. PubMed ID: 789235
    [No Abstract]   [Full Text] [Related]  

  • 9. A characteristic cutaneous direct immunofluorescent pattern associated with Ro(SS-A) antibodies in subacute cutaneous lupus erythematosus.
    Valeski JE; Kumar V; Forman AB; Beutner EH; Chorzelski TP
    J Am Acad Dermatol; 1992 Aug; 27(2 Pt 1):194-8. PubMed ID: 1430355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antinuclear antibody: significance of fluorescence patterns].
    Habermann F; de Franco MF
    Rev Hosp Clin Fac Med Sao Paulo; 1981 Jun; 36(3):123-7. PubMed ID: 7034129
    [No Abstract]   [Full Text] [Related]  

  • 11. [Differentiation with immunofluorescence of complement fixing and non-fixing antinuclear factors in patients with and without disseminated lupus erythematosus].
    Peltier AP
    Pathol Biol; 1968 Apr; 16(7):439-44. PubMed ID: 4882383
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antinuclear antibodies in disseminated lupus erythematosus and other connective tissue diseases].
    Velasco M; Losada M; Losada A; Ramirez G
    Rev Med Chil; 1968 Aug; 96(8):517-21. PubMed ID: 4915546
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anticentromere antibodies. Diagnostic and prognostic value].
    Meyer O; Haïm T
    Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Crithidia luciliae and Farr assays for the detection of systemic lupus erythematosus.
    Burdash NM; Teti G; Papadopoulos V
    Ann Clin Lab Sci; 1983; 13(1):49-54. PubMed ID: 6340594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of antinuclear autoantibodies by immunofluorescence technic in collagen diseases].
    Fontaine J; Panisset LC
    Union Med Can; 1969 Aug; 98(8):1274-83. PubMed ID: 4919613
    [No Abstract]   [Full Text] [Related]  

  • 16. The immunofluorescent tumor imprint technique. IV. The significance of "thready" nuclear immunofluorescence.
    Burnham TK; Neblett TR; Fine G; Bank P
    Arch Dermatol; 1969 May; 99(5):611-6. PubMed ID: 4889089
    [No Abstract]   [Full Text] [Related]  

  • 17. Cutaneous immunofluorescence.
    Weigand DA
    Med Clin North Am; 1989 Sep; 73(5):1263-74. PubMed ID: 2671545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunofluorescent "band" test for lupus erythematosus. II. Employing skin lesions.
    Burnham TK; Neblett TR; Fine G
    Arch Dermatol; 1970 Jul; 102(1):42-50. PubMed ID: 4925010
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunofluorescent studies in some autoimmune syndromes. I. Lupus erythematosus].
    Chorzelski T; Blaszczyk M
    Przegl Dermatol; 1971; 58(4):485-8. PubMed ID: 4938588
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical usefulness of detection of serum antinuclear antibodies by the immunofluorescence method].
    Wranicz A
    Przegl Dermatol; 1971; 58(6):685-90. PubMed ID: 4945137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.